17.1 C
Delhi
Monday, November 25, 2024

Torrent Pharma receives EIR from US FDA for Dahej facility

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Pharma major, Torrent pharma on Thursday said the US drug regulator US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for the company’s manufacturing facility at Dahej, Gujarat, and that the inspection has now been successfully closed by the US FDA.

Based on the March 2019 Inspection outcome, the Dahej facility was placed under “Official Action Indicated (OAI)” by the US FDA. The drug regulator had conducted re-inspection of the site in May 2023 from May 17, 23 to May 25, 23 and issued Form 483 with 2 observations.

The updated classification of site is VAI (voluntary action indicated) which indicates that Torrent will start to get approval of filed ANDAs. This will further enhance the company’s prospects and foster growth in the US market with its new product offerings.

The Dahej facility manufactures APIs and formulations for Torrent Pharma’s international markets.

Related articles

USIRC urges USA, India to forge economic partnership resilient to deep-state regime

The United States-India Relationship Council (USIRC) urges for a resilient, trusted, hassle-free, and robust business partnership between the...

Jharkhand: BJP’s campaign goes futile as Mahagathbandhan eyes victory

Early counting trends in the state of Jharkhand showcase that the JMM-led Mahagathbandhan is set to emerge victorious,...

INDI Bloc crosses majority mark in Jharkhand, leads on 50 seats

As the counting of votes goes on in the state of Jharkhand, as per the latest ECI figures,...

Mahayuti leads in Maharashtra, crosses majority mark in early trends

The counting of votes in Maharashtra began at 8 AM with postal ballots, and where the competition between...